Fca Corp Novartis Ag Transaction History

Fca Corp

$316 Million
Q3 2024

A detailed history of Fca Corp transactions in Novartis Ag stock. As of the latest transaction made, Fca Corp holds 23,816 shares of NVS stock, worth $2.5 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

23,816

Previous 23,668 0.63%

Holding current value

$2.5 Million

Previous $2.52 Million 8.73%

% of portfolio

0.87%

Previous 0.83%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $15,707 - $17,891	148 Added 0.63%	23,816 $2.74 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $38,786 - $44,988	419 Added 1.8%	23,668 $2.52 Million
Q1 2024 May 08, 2024	SELL	$95.27 - $108.47 $5,239 - $5,965	-55 Reduced 0.24%	23,249 $2.25 Million
Q4 2023 Feb 08, 2024	BUY	$92.27 - $101.54 $2,583 - $2,843	28 Added 0.12%	23,304 $2.35 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $71,047 - $78,847	750 Added 3.33%	23,276 $2.37 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $16,005 - $18,149	-173 Reduced 0.76%	22,526 $2.27 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $45,457 - $52,716	568 Added 2.57%	22,699 $2.09 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $5,666 - $6,939	75 Added 0.34%	22,131 $2.01 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $41,408 - $48,429	555 Added 2.58%	22,056 $1.68 Million
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $24,961 - $29,062	310 Added 1.46%	21,501 $1.82 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $66,491 - $75,214	830 Added 4.08%	21,191 $1.86 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $251,134 - $277,697	-3,151 Reduced 13.4%	20,361 $1.78 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $19,708 - $22,928	241 Added 1.04%	23,512 $1.92 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $9,461 - $10,450	-111 Reduced 0.47%	23,271 $2.12 Million
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $4,926 - $5,809	-59 Reduced 0.25%	23,382 $2 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $34,663 - $41,926	444 Added 1.93%	23,441 $2.21 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $36,305 - $40,222	-442 Reduced 1.89%	22,997 $2 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $3,156 - $3,552	-39 Reduced 0.17%	23,439 $2.05 Million
Q1 2020 May 20, 2020	BUY	$70.67 - $99.01 $38,444 - $53,861	544 Added 2.37%	23,478 $1.94 Million
Q4 2019 Feb 11, 2020	SELL	$84.35 - $95.37 $3,711 - $4,196	-44 Reduced 0.19%	22,934 $2.17 Million
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $38,493 - $42,417	-450 Reduced 1.92%	22,978 $2 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $26,390 - $32,480	350 Added 1.52%	23,428 $2.14 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $25,533 - $29,204	-339 Reduced 1.45%	23,078 $2.22 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $13,111 - $14,599	-178 Reduced 0.75%	23,417 $2.01 Million
Q3 2018 Oct 22, 2018	SELL	$66.94 - $77.43 $19,345 - $22,377	-289 Reduced 1.21%	23,595 $2.03 Million
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $1.55 Million - $1.75 Million	23,884 New	23,884 $1.8 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $1.72 Million - $2.06 Million	-24,437 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $7,956 - $8,540	-110 Reduced 0.45%	24,437 $2.05 Million
Q3 2017 Nov 09, 2017	BUY	$74.14 - $77.27 $1.82 Million - $1.9 Million	24,547	24,547 $2.11 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fca Corp , based on Form 13F filings with the SEC.

News

Stay updated on Fca Corp with notifications on news.

Account